JPMorgan Chase & Co. upgraded shares of Immunocore (NASDAQ:IMCR – Free Report) from a neutral rating to an overweight rating in a research report released on Wednesday, MarketBeat Ratings reports. JPMorgan Chase & Co. currently has $22.00 price objective on the stock. IMCR has been the subject of several other research reports. Oppenheimer raised their […] The post Immunocore (NASDAQ:IMCR) Raised to 'Overweight' at JPMorgan Chase & Co. first appeared on Daily Political .

https://www.dailypolitical.com/2023/09/16/immunocore-nasdaqimcr-raised-to-overweight-at-jpmorgan-chase-co.html

#dailypolitical